Effects of astragaloside IV on delaying kidney aging and its mechanisms

doi:10.12047/j.cjap.6300.2022.084

Abstract

Abstract: Objective: To investigate the mechanisms of Astragaloside Ⅳ on inhibiting apoptosis and delaying kidney aging in rats by regulating SIRT1/p53 signaling pathway. Methods: The aging model was established by subcutaneous injection of D-galactose 200 mg/(kg·d). SPF-grade healthy male SD rats were randomly divided into 4 groups: normal control group (intragastric infusion of 5 ml/(kg·d) normal saline), aging model group (intragastric infusion of 5 ml/(kg·d) normal saline), Astragaloside IV group (intragastric infusion of 40 mg/(kg·d) Astragaloside IV),and SRT1720 group( intragastric infusion of 20 mg/(kg·d) SRT1720), with 10 rats in each group. After 8 weeks, the serum samples of rats were collected to detect the levels of renal function (creatinine and urea nitrogen) and senescent associated secretory phenotype (TGF-β and IL-6) by ELISA. The renal tissues of rats were obtained for HE and Masson staining. The protein and mRNA expressions of SIRT1, p53, Bcl-2, Bax, p21 and pRb were detected by Western blot and RT-PCR. Results: Serum creatinine and urea nitrogen levels in the aging model group were higher than those in the normal group, but there was no significant difference in each group (P＞0.05). The serum levels of TGF-β and IL-6 in the aging model group were higher than those in the normal group (P＜0.05), and which in the Astragaloside IV group and SRT1720 group were lower than those in the model group (P＜0.05). There was no significant differences between Astragaloside IV group and SRT1720 group (P＞0.05). The results of pathological staining of renal tissues showed that, compared with the normal group, the renal tubules dilated, local atrophy, infiltration of inflammatory cells and proliferation of collagen fibers were observed in the aging model group. Compared with the aging model group, the pathological changes were alleviated in Astragaloside IV group and SRT1720 group. The results of Western blot and RT-PCR showed that, compared with the normal group, the protein and mRNA expressions of SIRT1 and pRb in the renal tissue of the aging group were decreased, the protein expression of Bcl-2 was decreased(P＜0.05), and the protein and mRNA expressions of p53 and p21 were increased, the protein expression of Bax was increased(P＜0.05). Compared with the aging group, Astragaloside IV and SRT1720 improved the above-mentioned indexes (P＜0.05). Conclusion: Astragaloside IV can delay kidney aging by regulating the SIRT1/p53 signaling pathway.

Key words: astragaloside IV, SIRT1/p53 signaling pathway, kidney, aging, apoptosis

CLC Number:

R57-2

ZHANG Zi-yuan, FANG Jing-ai, LI Su-fen, HU Ya-ling, LIU Wen-yuan, LIU Xue-jun. Effects of astragaloside IV on delaying kidney aging and its mechanisms[J]. CJAP, 2022, 38(5): 448-452.

References

[1] Musso CG, Jauregui JR. How to differentiate renal senescence from chronic kidney disease in clinical practice[J]. Postgrad Med, 2016, 128(7): 716-721.
[2] Irie J, Itoh H. Aging and homeostasis. Age-associated diseases and clinical application of NMN(Nicotinamide Mononucleotide)[J]. Clinical calcium, 2017, 27(7): 983-990.
[3] Zeisberg M, Neilson EG. Mechanisms of tubulointerstitial fibrosis[J]. J Am Soc Nephrol, 2010, 21(11): 1819-1834.
[4] 张伟光, 贾林沛, 白雪源. 肾脏衰老的功能变化及发生机制[J]. 老年医学与保健, 2016, 22(6): 329-331.
[5] 王倩, 梁艳, 杨胜楠, 等. 细胞衰老在老年小鼠急性肾损伤慢性化中的作用与机制研究[J]. 中华肾脏病杂志, 2018, 34(1): 44-51.
[6] 张继彬, 马赛, 范利, 等. 去乙酰化酶Sirtuins和细胞衰老与动脉粥样硬化的研究进展[J]. 中华老年多器官疾病杂志, 2018, 17(5): 378-382.
[7] 冯子奕, 李雪蕊 , 陈龙, 等. T16Ainh-A01 对耳蜗血管纹毛细血管内皮细胞凋亡及衰老的影响[J]. 中国应用生理学杂志, 2020, 36(5): 385-389.
[8] Ben Y, Hao J, Zhang Z, et al. Astragaloside IV inhibits mitochondrial-dependent apoptosis of the Dorsal root ganglion in diabetic peripheral neuropathy rats through modulation of the SIRT1/p53 signaling pathway[J]. Diabetes Metab Syndr Obes, 2021, 14(14): 1647-1661.
[9] Okamura DM, Pennathur S. The balance of powers: Redox regulation of fibrogenic pathways in kidney injury[J]. Redox Biol, 2015, 12(6): 495-504.
[10] Carrero JJ, Hecking M, Ulasi I, et al. Chronic kidney disease, gender, and access to care: A global perspective[J]. Semin Nephrol, 2017, 37(3): 296-308.
[11] Borghesan M, Hoogaars WMH, Varela-Eirin M, et al. A senescence-centric view of aging: Implications for longevity and disease[J]. Trends Cell Biol, 2020, 30(10): 777-791.
[12] Herranz N, Gil J. Mechanisms and functions of cellular senescence[J]. J Clin Invest, 2018, 128(4): 1238-1246.
[13] Kadota T, Fujita Y, Yoshioka Y, et al. Emerging role of extracellular vesicles as a senescence-associated secretory phenotype: Insights into the pathophysiology of lung diseases[J]. Mol Aspects Med, 2018, 60(4): 92-103.
[14] Schafer MJ, White TA, Iijima K, et al. Cellular senescence mediates fibrotic pulmonary disease[J]. Nat Commun, 2017, 23(8): 14532.
[15] Wiley CD, Velarde MC, Lecot P, et al. Mitochondrial dysfunction induces senescence with a distinct secretory phenotype[J]. Cell Metab, 2016, 23(2): 303-314.
[16] 孙伟铭, 张源洲, 温馨, 等. 外源性H2S恢复缺氧后适应对衰老H9C2细胞的保护作用及机制[J]. 中国应用生理学杂志,2018, 34(4): 289-293.
[17] 尚书英. 黄芪甲苷对辐射诱导脑细胞抗衰老机理的初探[D]. 兰州大学, 2019.
[18] Chen Q, Sun X, Luo X, et al. PIK3R3 inhibits cell senescence through p53/p21 signaling[J]. Cell Death Dis, 2020, 11(9): 798.
[19] Yamada K, Yoshida K. Mechanical insights into the regulation of programmed cell death by p53 via mitochondria[J]. Biochim Biophys Acta Mol Cell Res, 2019, 1866(5): 839-848.
[20]Chen C, Zhou M, Ge Y, et al. SIRT1 and aging related signaling pathways[J]. Mech Ageing Dev, 2020, 187(4): 111215.
[21] Johmura Y, Sun J, Kitagawa K, et al. SCF(Fbxo22)-KDM4A targets methylated p53 for degradation and regulates senescence[J]. Nat Commun, 2016, 12(7): 10574.
[22] Zhou H, Du W, Li Y, et al. Effects of melatonin on fatty liver disease: The role of NR4A1/DNA-PKcs/p53 pathway, mitochondrial fission, and mitophagy[J]. J Pineal Res, 2018, 64(1): 12450.
[23] Zhang Y, Yang X, Ge X, et al. Puerarin attenuates neurological deficits via Bcl-2/Bax/cleaved caspase-3 and Sirt3/SOD2 apoptotic pathways in subarachnoid hemorrhage mice[J]. Biomed Pharmacother, 2019, 109(5): 726-733.
[24] Kreis NN, Sanhaji M, Rieger MA, et al. p21Waf1/Cip1 deficiency causes multiple mitotic defects in tumor cells[J]. Oncogene, 2014, 33(50): 5716-5728.
[25] Li C, Xie N, Li Y, et al. N-acetylcysteine ameliorates cisplatin-induced renal senescence and renal interstitial fibrosis through sirtuin1 activation and p53 deacetylation[J]. Free Radic Biol Med, 2019, 130(1): 512-527.